Compare CYBN & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYBN | AMWL |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.9M | 111.4M |
| IPO Year | N/A | 2020 |
| Metric | CYBN | AMWL |
|---|---|---|
| Price | $6.62 | $4.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | ★ $74.50 | $8.33 |
| AVG Volume (30 Days) | ★ 610.5K | 116.6K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $265,023,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4.33 |
| 52 Week Low | $4.81 | $3.71 |
| 52 Week High | $10.73 | $12.95 |
| Indicator | CYBN | AMWL |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | 59.16 |
| Support Level | $5.70 | $3.92 |
| Resistance Level | $6.20 | $4.14 |
| Average True Range (ATR) | 0.35 | 0.22 |
| MACD | 0.08 | 0.12 |
| Stochastic Oscillator | 85.82 | 85.42 |
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.